Hartford Healthcare At Home Medicare Approved Location: 1 Northwestern Drive, Suite 101, Bloomfield, Connecticut 06002 Phone: (860) 249-4862 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).
The preprints selected for review in Rapid Reviews: COVID-19 (RR:C19), an open-access overlay journal published by the MIT Press, cover a wide range of subjects, with peer reviewers finding a study that higher levels of cytokines IL-6 and IL-10 are associated with increased severity of COVID-19 is particularly noteworthy and could be useful in clinical care.
NPR reports on the health care struggles of Howard County, Maryland, a well-off and generally liberal area with hospital fees set by the state and a county program for the uninsured. "But like the rest the country, Howard County is facing the impact of the recession: Employers have to cut back on benefits, so employees cut back on their coverage."
In honor of World AIDS Day, The AIDS Institute (TAI), one of the nation's leading advocacy organizations for support of people with HIV/AIDS and their providers, joined Nobel Laureate Dr. Francoise Barre-Sinoussi, in calling for government leaders, patient advocates and the research community to expand therapeutic HIV vaccine research.
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, today announced a new Data Quality Oversight service, RADAR, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level.
› Verified 6 days ago